Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 2 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Immunospot Assessment of T-Cell Responses in Preclinical Tumor Models with Undefined Target Antigens.
Methods Mol Biol. 2024;2773:165-174. doi: 10.1007/978-1-0716-3714-2_15.
Methods Mol Biol. 2024.
PMID: 38236545
Tumor cell-based vaccine contributes to local tumor irradiation by eliciting a tumor model-dependent systemic immune response.
Remic T, Sersa G, Levpuscek K, Lampreht Tratar U, Ursic Valentinuzzi K, Cör A, Kamensek U.
Remic T, et al.
Front Immunol. 2022 Sep 5;13:974912. doi: 10.3389/fimmu.2022.974912. eCollection 2022.
Front Immunol. 2022.
PMID: 36131926
Free PMC article.
Item in Clipboard
Maintenance and gene electrotransfer efficiency of antibiotic resistance gene-free plasmids encoding mouse, canine and human interleukin-12 orthologues.
Kamensek U, Rencelj A, Jesenko T, Remic T, Sersa G, Cemazar M.
Kamensek U, et al. Among authors: remic t.
Heliyon. 2022 Feb 2;8(2):e08879. doi: 10.1016/j.heliyon.2022.e08879. eCollection 2022 Feb.
Heliyon. 2022.
PMID: 35265755
Free PMC article.
Item in Clipboard
Development of Tumor Cell-Based Vaccine with IL-12 Gene Electrotransfer as Adjuvant.
Remic T, Sersa G, Ursic K, Cemazar M, Kamensek U.
Remic T, et al.
Vaccines (Basel). 2020 Mar 2;8(1):111. doi: 10.3390/vaccines8010111.
Vaccines (Basel). 2020.
PMID: 32121641
Free PMC article.
Item in Clipboard
Cite
Cite